Abstract
This chapter focuses on the selection of RNA aptamers, which bind to specific cell surface components and thus can be internalized receptor mediated. Such aptamers discriminate between different tissues, e.g., detect malignant cells, and target them or induce apoptosis through drug internalization. However, before starting the selection process the choice of an ideal target can be challenging. To give an example for the selection of cell specific aptamers, we here used the interleukin-6 receptor (IL-6R) as a target, which is presented on hepatocytes, neutrophils, monocytes, and macrophages.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Mager MD, LaPointe V, Stevens MM (2011) Exploring and exploiting chemistry at the cell surface. Nat Chem 3:582–589
Davis KA, Lin Y, Abrams B, Jayasena SD (1998) Staining of cell surface human CD4 with 2′-F-pyrimidine-containing RNA aptamers for flow cytometry. Nucleic Acids Res 26:3915–3924
Li N, Ebright JN, Stovall GM, Chen X, Nguyen HH, Singh A, Syrett A, Ellington AD (2009) Technical and biological issues relevant to cell typing with aptamers. J Proteome Res 8:2438–2448
Lupold SE, Hicke BJ, Lin Y, Coffey DS (2002) Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen. Cancer Res 62:4029–4033
Shangguan D, Tang Z, Mallikaratchy P, Xiao Z, Tan W (2007) Optimization and modifications of aptamers selected from live cancer cell lines. Chembiochem 8:603–606
Chu TC, Marks JW 3rd, Lavery LA, Faulkner S, Rosenblum MG, Ellington AD, Levy M (2006) Aptamer:toxin conjugates that specifically target prostate tumor cells. Cancer Res 66:5989–5992
Chu TC, Twu KY, Ellington AD, Levy M (2006) Aptamer mediated siRNA delivery. Nucleic Acids Res 34:e73
Farokhzad OC, Jon S, Khademhosseini A, Tran TN, Lavan DA, Langer R (2004) Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res 64:7668–7672
Ray P, Cheek MA, Sharaf ML, Li N, Ellington AD, Sullenger BA, Shaw BR, White RR (2012) Aptamer-mediated delivery of chemotherapy to pancreatic cancer cells. Nucleic Acid Ther 22:295–305
Kraus E, James W, Barclay AN (1998) Cutting edge: novel RNA ligands able to bind CD4 antigen and inhibit CD4+ T lymphocyte function. J Immunol 160:5209–5212
Meyer C, Eydeler K, Magbanua E, Zivkovic T, Piganeau N, Lorenzen I, Grotzinger J, Mayer G, Rose-John S, Hahn U (2012) Interleukin-6 receptor specific RNA aptamers for cargo delivery into target cells. RNA Biol 9:67–80
Kruspe S, Meyer C, Hahn U (2014) Chlorin e6 conjugated interleukin-6 receptor aptamers selectively kill target cells upon irradiation. Mol Ther Nucleic Acids 3:e143
Kruspe S, Hahn U (2014) An aptamer intrinsically comprising 5-fluoro-2′-deoxyuridine for targeted chemotherapy. Angew Chem Int Ed Engl 53:10541–10544
Gopinath SC (2007) Methods developed for SELEX. Anal Bioanal Chem 387:171–182
Jing M, Bowser MT (2013) Tracking the emergence of high affinity aptamers for rhVEGF165 during capillary electrophoresis-systematic evolution of ligands by exponential enrichment using high throughput sequencing. Anal Chem 85:10761–10770
Gu G, Wang T, Yang Y, Xu X, Wang J (2013) An improved SELEX-Seq strategy for characterizing DNA-binding specificity of transcription factor: NF-kappaB as an example. PLoS One 8:e76109
Schutze T, Wilhelm B, Greiner N, Braun H, Peter F, Morl M, Erdmann VA, Lehrach H, Konthur Z, Menger M, Arndt PF, Glokler J (2011) Probing the SELEX process with next-generation sequencing. PLoS One 6:e29604
Guo Y, Xu F, Lu T, Duan Z, Zhang Z (2012) Interleukin-6 signaling pathway in targeted therapy for cancer. Cancer Treat Rev 38:904–910
Ozbek S, Grotzinger J, Krebs B, Fischer M, Wollmer A, Jostock T, Mullberg J, Rose-John S (1998) The membrane proximal cytokine receptor domain of the human interleukin-6 receptor is sufficient for ligand binding but not for gp130 association. J Biol Chem 273:21374–21379
Mayer G, Ahmed MS, Dolf A, Endl E, Knolle PA, Famulok M (2010) Fluorescence-activated cell sorting for aptamer SELEX with cell mixtures. Nat Protoc 5:1993–2004
Meyer C, Hahn U, Rentmeister A (2011) Cell-specific aptamers as emerging therapeutics. J Nucleic Acids 2011:904750
Sefah K, Shangguan D, Xiong X, O’Donoghue MB, Tan W (2010) Development of DNA aptamers using Cell-SELEX. Nat Protoc 5:1169–1185
Ibach J, Dietrich L, Koopmans KR, Nobel N, Skoupi M, Brakmann S (2013) Identification of a T7 RNA polymerase variant that permits the enzymatic synthesis of fully 2′-O-methyl-modified RNA. J Biotechnol 167:287–295
Padilla R, Sousa R (2002) A Y639F/H784A T7 RNA polymerase double mutant displays superior properties for synthesizing RNAs with non-canonical NTPs. Nucleic Acids Res 30:e138
Meyer C, Berg K, Eydeler-Haeder K, Lorenzen I, Grotzinger J, Rose-John S, Hahn U (2014) Stabilized Interleukin-6 receptor binding RNA aptamers. RNA Biol 11:57–65
Faryammanesh R, Lange T, Magbanua E, Haas S, Meyer C, Wicklein D, Schumacher U, Hahn U (2014) SDA, a DNA aptamer inhibiting E- and P-selectin mediated adhesion of cancer and leukemia cells, the first and pivotal step in transendothelial migration during metastasis formation. PLoS One 9:e93173
Shao K, Ding W, Wang F, Li H, Ma D, Wang H (2011) Emulsion PCR: a high efficient way of PCR amplification of random DNA libraries in aptamer selection. PLoS One 6:e24910
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2016 Springer Science+Business Media New York
About this protocol
Cite this protocol
Berg, K., Magbanua, E., Hahn, U. (2016). SELEX of Cell-Specific RNA Aptamers. In: Mayer, G. (eds) Nucleic Acid Aptamers. Methods in Molecular Biology, vol 1380. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-3197-2_2
Download citation
DOI: https://doi.org/10.1007/978-1-4939-3197-2_2
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-3196-5
Online ISBN: 978-1-4939-3197-2
eBook Packages: Springer Protocols